BioLife Solutions Statistics

Total Valuation

BLFS has a market cap or net worth of $1.14 billion. The enterprise value is $1.15 billion.

Market Cap	1.14B
Enterprise Value	1.15B

Important Dates

The last earnings date was Monday, March 3, 2025, before market open.

Earnings Date	Mar 3, 2025
Ex-Dividend Date	n/a

Share Statistics

BLFS has 46.39 million shares outstanding. The number of shares has increased by 5.37% in one year.

Current Share Class	46.39M
Shares Outstanding	46.39M
Shares Change (YoY)	+5.37%
Shares Change (QoQ)	+4.02%
Owned by Insiders (%)	3.26%
Owned by Institutions (%)	83.56%
Float	36.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.73
Forward PS	12.16
PB Ratio	3.28
P/TBV Ratio	3.26
P/FCF Ratio	134.85
P/OCF Ratio	134.85
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	136.97

Financial Position

The company has a current ratio of 4.54, with a Debt / Equity ratio of 0.05.

Current Ratio	4.54
Quick Ratio	n/a
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	2.12
Interest Coverage	-9.92

Financial Efficiency

Return on equity (ROE) is -3.32% and return on invested capital (ROIC) is -1.19%.

Return on Equity (ROE)	-3.32%
Return on Assets (ROA)	-1.10%
Return on Invested Capital (ROIC)	-1.19%
Return on Capital Employed (ROCE)	-1.94%
Revenue Per Employee	$198,681
Profits Per Employee	-$48,754
Employee Count	414
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

Income Tax	-38,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +36.39% in the last 52 weeks. The beta is 2.04, so BLFS's price volatility has been higher than the market average.

Beta (5Y)	2.04
52-Week Price Change	+36.39%
50-Day Moving Average	26.66
200-Day Moving Average	24.28
Relative Strength Index (RSI)	38.76
Average Volume (20 Days)	298,137

Short Selling Information

The latest short interest is 3.37 million, so 7.27% of the outstanding shares have been sold short.

Short Interest	3.37M
Short Previous Month	3.27M
Short % of Shares Out	7.27%
Short % of Float	9.33%
Short Ratio (days to cover)	14.15

Income Statement

In the last 12 months, BLFS had revenue of $82.25 million and -$20.18 million in losses. Loss per share was -$0.44.

Revenue	82.25M
Gross Profit	53.67M
Operating Income	-7.13M
Pretax Income	-73.25M
Net Income	-20.18M
EBITDA	-4.39M
EBIT	-7.13M
Loss Per Share	-$0.44

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	17.84M
Net Cash	-17.84M
Net Cash Per Share	-$0.38
Equity (Book Value)	348.91M
Book Value Per Share	7.48
Working Capital	116.03M

Full Balance Sheet

Cash Flow

Operating Cash Flow	8.43M
Capital Expenditures	n/a
Free Cash Flow	8.43M
FCF Per Share	$0.18

Full Cash Flow Statement

Margins

Gross margin is 65.25%, with operating and profit margins of -8.67% and -24.54%.

Gross Margin	65.25%
Operating Margin	-8.67%
Pretax Margin	-13.89%
Profit Margin	-24.54%
EBITDA Margin	-5.34%
EBIT Margin	-8.67%
FCF Margin	10.25%

Dividends & Yields

BLFS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.37%
Shareholder Yield	-5.37%
Earnings Yield	-1.78%
FCF Yield	0.74%

Analyst Forecast

The average price target for BLFS is $29.43, which is 20.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.43
Price Target Difference	20.07%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	11.33%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 29, 2014. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date	Jan 29, 2014
Split Type	Reverse
Split Ratio	0.0714285:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	5